« Previous
Next »
Seminars in Oncology
Volume 36
, Pages
S35-S45
, August 2009
Diagnostic Tools for Neoplastic Meningitis: Detecting Disease, Identifying Patient Risk, and Determining Benefit of Treatment
-
Proposed clinical trial design for assessing the diagnostic utility of biomarkers in patients at high risk for developing neoplastic meningitis (NM). CSF, cerebrospinal fluid; IT, intrathecal; PF Mets
Proposed clinical trial design for assessing the diagnostic utility of biomarkers in patients at high risk for developing neoplastic meningitis (NM). CSF, cerebrospinal fluid; IT, intrathecal; PF Mets, posterior fossa metastasis.
STATEMENT OF CONFLICT OF INTEREST: All four authors have received honorarium from Enzon Pharmaceuticals, as well as serving on the Enzon speaker's bureau. M.G. and M.D.G. have received research support from Enzon Pharmaceuticals.
PII: S0093-7754(09)00095-5
doi: 10.1053/j.seminoncol.2009.05.005
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Oncology
Volume 36
, Pages
S35-S45
, August 2009
